DiscoveryProbe™ FDA-approved Drug Library Mini

New drug development is typically a time-consuming and costly process with a high failure rate. In contrast, drug repositioning (or "old drug, new use") offers significant advantages, including a lower risk of development failure, shorter research and development cycles, and reduced costs. Approved drugs are ideal for repositioning studies because their biological activity, pharmacokinetic properties, and safety profiles are already well-established.
The DiscoveryProbe™ FDA Approved Drug Library contains 1596 bioactive compounds approved by major global regulatory agencies such as the FDA, EMA, HMA, CFDA, and PMDA. The biological activity and safety of these drugs have been extensively confirmed in vitro and in vivo, and they've undergone comprehensive preclinical and clinical studies, ensuring good bioavailability. Therefore, this library is particularly well-suited for high-throughput screening (HTS) and high-content screening (HCS), allowing for the discovery of new targets for existing drugs and serving as a powerful tool to accelerate the drug development process.

Potent Biological Activity: Features strong biological activity, high selectivity, and cell permeability, enabling effective inhibition or activation of targets.

Diverse Chemical Structures & Administration Routes: Offers a wide array of chemical structures and various administration routes (e.g., oral, intramuscular injection, intravenous injection).

Comprehensive Documentation: Provides detailed documentation, including information on compound potency, selectivity, and specific application areas.

Extensive Literature & Customer Validation: Backed by extensive and authoritative literature support and positive customer feedback.

Purity Verified: Compound purity is assured through NMR and HPLC analysis.